Patents/Assignees

In3bio Ltd.

6 patents in portfolio

US12595297utility2026
Methods and Compositions for Inhibition of EGF/EGFR Pathway in Combination with Tyrosine Kinase Inhibitors
0 cites
US12433939utility2025
Self-assembling Synthetic Proteins Comprising Cholera Toxin Beta Subunit
0 cites
US12257245utility2025
Methods and Compositions for Inhibition of EGF/EGFR Pathway in Combination with Anaplastic Lymphoma Kinase Inhibitors
0 cites
US12258389utility2025
Methods and Compositions for Inhibition of EGF/EGFR Pathway in Combination with Tyrosine Kinase Inhibitors
0 cites
US12134662utility2024
Synthetic Proteins and Therapeutic Uses Thereof
0 cites
US12030920utility2024
Recombinant Proteins and Their Therapeutic Uses
0 cites